Markers of Brain Damage in Severe Concomitant Injury
https://doi.org/10.15360/1813-9779-2010-2-71
Abstract
The paper describes a clinical case of early enteral feeding with an immune formula in a patient with significant heart failure after cardiosurgical intervention who is on venoarterial extracorporeal membrane oxygenation. The safety and efficiency of nutritional support were monitored, by estimating blood acid-base balance and oxygenation level and by controlling the residual gastric volume, which enabled the volume of the given enteral mixture to be increased up to 2600 kcal by day 3, by providing the body’s energy needs determined by calculation techniques. On postoperative day 4 when hemodynamic parameters were satisfactory, extracorporeal membrane oxygenation was disconnected; following 7 days the patient was weaned from artificial ventilation. The length of intensive care unit stay was 14 days. The patient was discharged from hospital in a satisfactory condition. Thus, early enteral feeding may be a safe and effective method of nutritional support in patients on extracorporeal circulation. Key words: extracorporeal membrane oxygenation, early enteral feeding, immune nutrition, cardiosurgery.
References
1. Сингаевский А. Б., Карнасевич Ю. А., Малых И. Ю.
2. Шах Б. Н.Диагностика и коррекция нарушений гомеостаза у пострадавших с механическими шокогенными повреждениями в остром периоде травматической болезни: автореф. дис. … д-ра мед. наук. СПб.; 2006: 4
3. Багненко С. Ф., Шах Б. Н., Теплов В. М.Возможности коррекции ги-поксических и реперфузионных повреждений у пострадавших с со-четанной шокогенной травмой в остром периоде травматической болезни. В кн.: Тезисы докладов Всероссийской конференции «Реаниматология — наука о критических состояниях». М.; 2006. 11 — 12.
4. Ганнушкина И. В.Иммунологические аспекты травмы и сосудистых поражений мозга. М.: Медицина; 199
5. Gentleman S. M., Leclercq P. D., Moyes L. et al.Long-term intracerebral inflammatory response after traumatic brain injury. Forensic. Sci. Int. 2004; 146 (2—3): 97—104.
6. Wang X., Feuerstein G. Z.Role of immune and inflammatory mediators in CNS injury. Drug News Perspect. 2000; 13 (3): 133—140.
7. Andrews P. J., Piper I. R., Dearden N. M., Miller J. D.Secondary insults during intrahospital transport of head injured patients. Lancet 1990; 335 (8685): 327—330.
8. Dorsch N. W., Zurynski Y. A.Post-traumatic vasospasm influences head injury outcome. Can. J. Neurol. Sci. 1993; 10: 2
9. Шанин В. Ю.Патофизиология критических состояний. СПб.: ЭЛ-БИ-СПб.; 2003. 436.
10. Будаев А. В.Тканевой кровоток головного мозга в постреанимационном периоде у животных, перенесших клиническую смерть. Общая реаниматология 2006; II (5—6): 79—84.
11. Заржецкий Ю. В., Аврущенко М. Ш., Волков А. В.Нейрофизиологические механизмы постреанимационного повреждения мозга. Общая реаниматология 2006; II (5—6): 101 — 110.
12. Острова И. В., Мороз В. В., Аврущенко М. Ш.Значение иммуногис-тохимических исследований белков теплового шока семейства HSP 70 для изучения постреанимационных изменений мозга. Общая реаниматология 2007; III (5—6): 91—96.
13. Aguilar L. C, Islas A., Rosique P. et al.Psychometric analysis in children with mental retardation due to perinatal hypoxia treated with fibrob-last growth factor (FGF) & showing improvement in mental development. J. Intellect Disabil. Res. 1993; 37 (Pt 6): 507—520.
14. Kubo T.Brain-derived neurotrophic factor (BDNF) can prevent apop-tosis of rat cerebellar granule neurons in culture. Brain Res. Dev. Brain Res. 1995; 85 (2): 249—258.
15. Петрищев Н. Н., Беркович О. А, Власов Т. Д. и соавт.Диагностическая ценность циркулирующих эндотелиальных клеток в крови. Клинич. лаб. диагностика 2001; 1: 50—52.
16. Dimmeler S, Hermann C., Zeiher A. M.Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? Eur. Cytokine Netw. 1998; 9 (4): 697—698.
17. ЖдановГ. Н, ГерасимоваМ. М.Оценка роли аутоиммунной воспалительной реакции в патогенезе церебральной ишемии. Невролог. вестн. 2003; 35 (3—4): 13—
18. Скворцова В. И, Шерстнёв В. В., Константинова Н. А. и соавт.Участие аутоиммунных механизмов в развитии ишемического повреждения головного мозга. Журн. неврологии и психиатрии им. С. С. Корсакова 2005; 105 (8): 36—40.
19. Чехонин В. П., Гурина О. И., Рябухин И. А. и соавт.Иммунофермент-ный анализ нейронспецифической енолазы на основе монокло-нальных антител в оценке проницаемости гематоэнцефалического барьера при нервно-психических заболеваниях. Росс. психиатр. журн. 2000; 4: 15—
20. Lamers K. J, van Engelen B. G., Gabreels F. J. et al.Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol. Scand. 1995; 92 (3): 247—251.
21. Missler U, Wiesmann M., Friedrich C., Kaps M.S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28 (10): 1956—1960.
22. Шумахер Г. И., Воробьёва Е. Н., Нечунаева Е. В. и соавт.Роль дисфункции эндотелия в запуске иммунопатологических реакций при хронической ишемии головного мозга. Бюл. Сибирской медицины 2008; 5: 214—219.
23. Крижановский Г. Н.Общая патофизиология нервной системы. М.; 1997. 349.
24. Гурина О. И.Клинико-иммунохимическая оценка нарушений функций гемато-энцефалического барьера у недоношенных детей с перинатальными поражениями ЦНС: автореф. дис. … канд. мед. наук. М.; 1996.
25. Moore B. W.A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 1965; 19 (6): 739—744.
26. Zimmer D.B., Cornwall E.H., Landar A., Song W.The S100 protein family: history, function, and expression. Brain Res. Bull. 1995; 37 (4): 417—429.
27. Donato R.S-100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 2001; 33 (7): 637—668.
28. Heizmann C. W.Ca2+-binding S100 proteins in the central nervous system. Neurochem. Res. 1999; 24 (9): 1097—1100.
29. Petzold A., Green A. J., Keir G. et al.Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study. Crit. Care Med. 2002; 30 (12): 2705—2710.
30. Raabe A., Grolms C., Sorge O. et al.Serum of S-100 protein in severe head injury. Neurosurgery 1999; 45 (3): 477—483.
31. Raabe A., Grolms C., Seifert V.Serum markers of brain damage and outcome prediction after severe head injury. Br. J. Neurosurg. 1999; 13 (1): 56—59.
32. Ingebrigtsen T., Waterloo K., Jacobsen E. A. et al.Traumatic brain damage in minor head injury: relation of serum S100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45 (3): 468—476.
33. Mussack T., Biberthaler P., Kanz K. G. et al.Serum S-100B and inter-leukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit. Care Med. 2002; 30 (12): 2669—2674.
34. Bottiger B. W., Mobes S., Glatzer R. et al.Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103 (22): 2694—2698.
35. Mussack T., Biberthaler P., Kanz K. G. et al.Immediate S100B and neuron-specific enolase plasma measurements or rapid evaluation of primary brain damage in alcoholintoxicated, minor head-injured patients. Shock 2002; 18 (5): 395—400.
36. Ali M. S., Harmer M., Vaughan R.Serum protein S100 as a marker of cerebral damage during cardiac surgery. Br. J. Anaesth. 2000; 85 (2): 287—298.
37. Wiesmann M., Missler U., Hagenstrom H., Gottmann D.S-100 protein plasma levels after aneurismal subarachnoid haemorrhage. Acta Neurochir. (Wien) 1997; 139 (12): 1155—1160.
38. Pelinka L. E., Bahrami S., Szalay L. et al.Hemorrhagic shock induces an S100B increase associated with shock severity. Shock 2003; 19 (5): 422—426.
39. Pelinka L. E., Szalay L., Jafarmadar M. et al.Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br. J. Anaesth. 2003; 91 (4): 595—597.
40. Pelinka L. E., Toegel E., Mauritz W., Redl H.Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003; 19 (3): 195—200.
41. Biberthaler P., Linsenmeier U., Pfeifer K. J. et al.Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury: A prospective multi-center study. Shock 2006; 25 (5): 446—453.
42. Hayakata T., Shiozaki T., Tasaki O. et al.Changes in CSF S100b and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004; 22 (2): 102—107.
43. Marangos P. J., Schmechel D. E.Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu. Rev. Neurosci. 1987; 10: 269—295.
44. Woertgen C., Rothoerl R. D., Holzschuh M. et al.Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir. (Wien) 1997; 139 (12): 1161—1165.
45. Martens P., Raabe A., Johnsson P.Serum S-100 and neuron-specific eno-lase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29 (11): 2363—2366.
46. Georgiadis D., Berger A., Kowatchev E. et al.Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J. Thorac. Cardiovasc. Surg. 2000; 119 (1): 138—147.
47. Wunderlich M. T., Ebert A. D., Kratz T. et al.Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30 (6): 1190—1195.
48. Rosen H., Sunnerhagen K. S., Herlitz J. et al.Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001; 49 (2): 183—191.
49. Weigand M. A., Volkmann M., Schmidt H. et al.Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis and septic shock. Anesthesiology 2000; 92 (3): 905—907.
50. Moreno R., Vincent J. L., Matos R. et al.The use of the maximum SOFA score to quantify organ dysfunction/failure in intensive care: Results of a prospective, multicenter study. Intensive Care Med. 1999; 25 (7): 686—696.
51. Bleck T. P., Smith M. C., Pierre-Louis S.J. et al.Neurologic complications of critical medical illness. Crit. Care Med. 1993; 21 (1): 98—103.
52. Eidelman L. A., Putterman D., Putterman C., Sprung C. L.The spectrum of septic encephalopathy: Definitions, etiologies and mortalities. JAMA 1996; 275 (6): 470—473.
53. Gogos C. A., Lekkou A., Papageorgiou O. et al.Clinical prognostic markers in patients with severe sepsis: A prospective analysis of 139 consecutive patients. J. Infect. 2003; 47 (4): 300—306.
54. Young G. B.Septic encephalopathy. In: Yearbook of Intensive Care and Emergency Medicine. Vincent J. L. (Ed.). New York: Springer; 2002: 748—753.
55. Marshall J. C., Cook D. J., Christou N. V. et al.Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit. Care Med. 1995; 23 (10): 1638—1652.
56. Nguyen D. N., Spapen H., Su F. et al.Elevated serum levels of S-100/3 protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit. Care Med. 2006; 34 (7): 1967—1974.
57. Routsi C., Stamataki E., Nanas S. et al.Increased levels of serum s100b protein in critically ill patients without brain injury. Shock 2006; 26 (1): 20—24.
Review
For citations:
Grigoryev Ye.V., Kameneva Ye.A., Grishanova T.G., Deragin M.N., Budayev A.V. Markers of Brain Damage in Severe Concomitant Injury . General Reanimatology. 2010;6(2):71. (In Russ.) https://doi.org/10.15360/1813-9779-2010-2-71
Views:
1513
Email this article 